Intensity Therapeutics, Inc. (INTS) Income Statement
28 Followers
Intensity Therapeutics, Inc. Income Statement
Last quarter (Q3 2024), Intensity Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q3, Intensity Therapeutics, Inc.'s net income was $-3.51M. See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 8.32M
Operating Income
$ -8.32M
Net Non Operating Interest Income Expense
$ 19.00K
Other Income Expense
$ -2.24M
Pretax Income
$ -10.54M
Tax Provision
$ -350.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -11.86M
Basic EPS
$ -1.38
Diluted EPS
$ -1.38
Basic Average Shares
$ 8.62M
Diluted Average Shares
$ 8.62M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 8.32M
Net Income From Continuing And Discontinued Operation
$ -10.54M
Normalized Income
$ -10.89M
Interest Expense
-
EBIT
$ -10.23M
EBITDA
$ -10.23M
Currency in USD
Intensity Therapeutics, Inc. Earnings and Revenue History